Nephrology Dialysis Transplantation, Vol 13, Issue 10 2553-2558, Copyright © 1998 by Oxford University Press
M Freire, D van Dijk, A Erman, G Boner, J Warram and A Krolewski
Background. To determine the relationship between DNA
polymorphisms in the angiotensin I converting enzyme (ACE) gene, serum ACE
activity and the risk of diabetic nephropathy. Methods.
A case-control study was carried out in a population of Jewish
insulin-dependent diabetes melitus (IDDM) patients. Cases (77 IDDM patients
with diabetic nephropathy) and controls (89 IDDM patients with
normoalbuminuria) were genotyped with PCR protocols for detecting two DNA
polymorphisms in the ACE gene: one in intron 7 detected with the
restriction enzyme PstI and the other in intron 16
identified as an insertion/deletion (I/D). Results.
The risk of nephropathy was increased only in patients
homozygous for the allele with the PSTI site. These
homozygotes had a nephropathy risk that was 2.3 times (95% C.I.: 1.2-4.5)
that of the other genotypes. Furthermore, these individuals did not have
elevated serum ACE activity. Conclusions. The results
of this study are evidence that the risk of diabetic nephropathy in IDDM is
influenced by genetic variability at the ACE locus, but the responsible
variant is not the I/D polymorphism in intron 16. Our findings require
further studies in other populations.
ORIGINAL ARTICLES
DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes melitus
Research Division, Joslin Diabetes Centre and Department of Medicine, One Joslin Place, Boston, MA 02215, USA; Institute of Hypertension and Kidney Diseases, Rabin Medical Centre, Beilinson Medical Centre, Petach Tikwa and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Current address: Faculdade de Medicina de Jundiai, Jundiai, Brazil; Corresponding author
![]()
CiteULike
Connotea
Del.icio.us What's this?